Bacterial asparaginase: A potential antineoplastic agent for treatment of acute lymphoblastic leukemia

Bacteria and Cancer

Volumn 9789400725850, Issue , 2012, Pages 225-244

  Shrivastava, Abhinav ^a   Khan, Abdul Arif ^a,b   Jain, S K ^c   Singhal, P K ^d  

^a Cancer Hospital and Research Institute   (India)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c VIKRAM UNIVERSITY   (India)

^d RANI DURGAVATI UNIVERSITY   (India)

Author keywords

ALL; Antineoplastic; Asparaginase; Bacterial enzymes; Chemotherapy; Fusarium; Leukemia; Pegaspargase

Indexed keywords

EID: 84867364936     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-007-2585-0_10     Document Type: Chapter

References (121)

1. Abuchowski A, Kazo GM, Verhoest CR et al (1984) Cancer therapy with chemically modified enzymes. I. Antitumor properties of polyethylene glycol asparaginase conjugates. Cancer Biochem Biophys 7(2):175-186
2. Adamson RH, Fabro S (1968) Antitumor activity and other biological properties of L-asparaginase (NSC - 109229) - a review. Cancer Chemother Rep 52(6):617-626
3. Aghaiypour K, Wlodawer A, Lubkowski J (2001) Structural basis for the activity and substrate specificity of Erwinia chrysanthemi L-asparaginase. Biochemistry 40(19):5655-5664. doi: dx.doi.org
4. Alpar HO, Lewis DA (1985) Therapeutic efficacy of asparaginase encapsulated in intact erythrocytes. Biochem Pharmacol 34(2):257-261
5. American Cancer Society (2010) Cancer facts and figure 2010. http://www.cancer.org/acs/groups/content/@nho/documents/document/acspc-024113.pdf
6. Asselin BL (1999) The three asparaginases. Comparative pharmacology and optimal use in childhood leukemia. Adv Exp Med Biol 457:621-629
7. Asselin BL, Ryan D, Frantz CN et al (1989) In vitro and in vivo killing of acute lymphoblastic leukemia cells by L-asparaginase. Cancer Res 49(15):4363-4368
8. Asselin BL, Lorenson M Y, Whitin JC et al (1991) Measurement of serum L-asparagine in the presence of L-asparaginase requires the presence of an L-asparaginase inhibitor. Cancer Res 51(24):6568-6573
9. Athale UH, Chan AKC (2003) Thrombosis in children with acute lymphoblastic leukemia: Part II. Pathogenesis of thrombosis in children with acute lymphoblastic leukemia: effects of the disease and therapy. Thromb Res 111(4-5):199-212
10. Avramis VI, Panosyan EH (2005) Pharmacokinetic/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future. Clin Pharmacokinet 44(4):367-393
11. Avramis VI, Tiwari PN (2006) Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia. Int J Nanomedicine 1(3):241-254
12. Avramis VI, Sencer S, Periclou AP et al (2002) A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study. Blood 99(6):1986-1994
13. Avramis VI, Avramis E V, Hunter W et al (2009) Immunogenicity of native or pegylated E. coli and Erwinia asparaginases assessed by ELISA and surface plasmon resonance (SPR-Biacore) assays of IgG antibodies (Ab) in sera from patients with acute lymphoblastic leukemia (ALL). Anticancer Res 29(1):299-302
14. Bagert U, Rohm KH (1989) On the role of histidine and tyrosine residues in E. coli asparaginase. Chemical modification and 1 H-nuclear magnetic resonance studies. Biochim Biophys Acta 999(1):36-41
15. Bartalena L, Martino E, Antonelli A et al (1986) Effect of the antileukemic agent L-asparaginase on thyroxine-binding globulin and albumin synthesis in cultured human hepatoma (HEP G2) cells. Endocrinology 119(3):1185-1188
16. Becker FF, Broome JD (1967) L-asparaginase: inhibition of early mitosis in regenerating rat liver. Science 156(3782):1602-1603
17. Bodmer M, Sulz M, Stadlmann S et al (2006) Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase. Digestion 74(1):28-32
18. Borisova AA, El'darov MA, Zhgun AA et al (2003) Purification and properties of recombinant Erwinia carotovora L-asparaginase expressed in E. coli cells. Biomed Khim 49(5):502-507
19. Boss J (1997) Pharmacokinetics and drug monitoring of L-asparaginase treatment. Int J Clin Pharmacol Ther 35(3):96-98
20. Boyse EA, Old LJ, Campbell HA et al (1967) Suppression of murine leukemias by L-asparaginase. Incidence of sensitivity among leukemias of various types: comparative inhibitory activities of guinea pig serum L-asparaginase and Escherichia coli L-asparaginase. J Exp Med 125(1):17-31
21. Broome JD (1961) Evidence that the L-asparaginase activity of guinea pig serum is responsible for its antilymphoma effects. Nature 191:1114-1115
22. Broome JD (1963) Evidence that the L-asparaginase activity of guinea pig serum is responsible for its anti-lymphoma effects. I. Properties of the L-asparaginase of guinea pig serum in relation to those of the antilymphoma substance. J Exp Med 118:99-120
23. Broome JD (1965) Antilymphoma activity of L-asparaginase in vivo: clearance rates of enzyme preparations from guinea pig serum and yeast in relation to their effects on tumor growth. J Natl Cancer Inst 35(6):967-974
24. Broome JD (1968) L-asparaginase: the evolution of a new tumor inhibitory agent. Trans NY Acad Sci 30(5):690-704
25. Broome JD (1981) L-asparaginase: discovery and development as a tumor inhibitory agent. Cancer Treat Rep 65(Suppl 4):111-114
26. Burchenal JH, Karnofsky DA (1970) Clinical evaluation of L-asparaginase. Introduction. Cancer 25(2):241-243
27. Cairo MS (1982) Adverse reactions of L-asparaginase. Am J Pediatr Hematol Oncol 4(3):335-339
28. Campbell HA, Mashburn LT, Boyse EA et al (1967) Two L-asparaginases from Escherichia coli B. Their separation, purification and antitumor activity. Biochemistry 6(3):721-730
29. Capizzi RL, Cheng YC (1981) Therapy of neoplasia with asparaginase. In: Holcenberg J, Roberts J (eds) Enzymes as drugs. Wiley, New York
30. Capizzi RL, Holcenberg JS (1993) Asparaginases. In: Holland JF, Frei E, Bast RC et al (eds) Cancer medicine, 3rd edn. Lea & Febiger, Philadelphia
31. Capizzi RL, Bertino JR, Handschumacher RE (1970) L-asparaginase. Ann Rev Med 21:433-444
32. Carter P, Wells JA (1988) Dissecting the catalytic triad of a serine protease. Nature 332(6164):564-568
33. Chabner B (1990) Enzyme therapy, L-asparaginase. In: Chabner B, Collins J (eds) Cancer chemotherapy: principles and practice. Lippincott, Philadelphia
34. Chabner BA, Loo TL (1996) Enzyme therapy: L-asparaginase. In: Chabner BA, Longo DL (eds) Cancer chemotherapy and biotherapy, principles and practice, 2nd edn. Lippincott-Raven Publishers, Philadelphia
35. Chakrabarti R, Schuster SM (1997) L-asparaginase: perspectives on the mechanisms of action and resistance. Int J Pediatr Hematol Oncol 4:597-611
36. Clavell LA, Gelber RD, Cohen HJ et al (1986) Four agent induction and intensive asparaginase therapy for treatment of childhood acute lyphobalastic leukemia. New Engl J Med 315(11):657-663
37. Clayson DB (2001) Toxicological carcinogenesis. Lewis Publishers, Boca Raton
38. Clementi A (1922) La desamidation enzymatique de l'asparagine chez les differentes especes animals et la signification physiologique de sa presence dans l'organisme. Arch Intern Physiol 19:369-398
39. Davidson L, Burkom M, Ahn S et al (1977) l-Asparaginases from Citrobacter freundii. Biochim Biophys Acta 480(1):282-294
40. De-Angeli CL, Pocchiari F, Russi S et al (1970) Effect of L-asparaginase from Aspergillus terreus on ascites sarcoma in the rat. Nature 225(5232):549-550
41. Derst C, Wehner A, Specht V et al (1994) State and function of tyrosine residues in Escherichia coli asparaginase II. Eur J Biochem 224(2):533-540
42. Dhall G, Robison NJ, Rubin JI et al (2008) Incidence of adverse reactions to post-induction asparaginase (ASP) therapy in children and adolescents with high risk acute lymphoblastic leukemia (ALL): a report from the children's oncology group study CCG-1961. J Clin Oncol 26: abstr 10021
43. Distasio JA, Nredrerman RA, Kafkewitz D et al (1976) Purification and characterization of L-asparaginase with anti lymphoma activity from Vibrio succinogenes. J Biol Chem 251(22):6929-6933
44. Earl M (2009) Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia. Clin Adv Hematol Oncol 7(9):600-606
45. El-Bessoumy AA, Sarhan M, Mansour J (2004) Production, isolation, and purification of L-asparaginase from Pseudomonas aeruginosa 50071 using solid-state fermentation. J Biochem Mol Biol 37(4):387-393
46. Emery J, Lucassen A, Murphy M (2001) Common hereditary cancers and implications of primary care. Lancet 358(9275):56-63
47. Fromenty B, Pessayre D (1995) Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther 67(1):101-154
48. Fromenty B, Pessayre D (1997) Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines. J Hepatol 26(suppl 2):43-53
49. Furth O, Friedmann M (1910) Uber die verbreitung asparaginspaltender organfermente. Biochem Z 26:435-440
50. Gaffar SA, Shethna YI (1975) Partial purification and antitumour activity of L-asparaginase from Azotobacter vinelandi. Curr Sci 44:727-729
51. Gallagher MP, Marshall RD, Wilson R (1989) Asparaginase as a drug for treatment of acute lymphoblastic leukaemia. Essays Biochem 24:1-40
52. Gaynon PS (2005) Childhood acute lymphoblastic leukaemia and relapse. Br J Haematol 131(5):579-587
53. Goody HE, Ellem KA (1975) Nutritional effects on precursor uptake and compartmentalization of intracellular pools in relation to RNA synthesis. Biochim Biophys Acta 383(1):30-39
54. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57-70
55. Haskell CM, Canellos GP (1969) L-asparaginase resistance in human leukemia-asparagine synthetase. Biochem Pharmacol 18(10):2578-2580
56. Hellman K, Miller DS, Cammack KA (1983) The effect of freeze-drying on the quarternary structure of L-asparaginase from Erwinia carotovora. Biochim Biophys Acta 749(2):133-142
57. Hernandez-Espinoza D, Minano A, Martinez C et al (2006) L-Asparaginase-induced antithrombin type I deficiency: implication for conformational diseases. Am J Pathol 169(1):142-153
58. Hill JM, Roberts J, Loeb E et al (1967) L-asparaginase therapy for leukemia and other malignant neoplasms. Remission of human leukemia. J Am Med Assoc 202(9):882-888
59. Hirsch J (2006) An anniversary for cancer chemotherapy. JAMA 296(12):1518-1520
60. Ho DH, Wang CY, Lin JR et al (1988) Polyethylene glycol-L-asparaginase and L-asparaginase studies in rabbits. Drug Meta Dispos 16(1):27-29
61. Holcenberg JS, Teller DC (1976) Physical properties of antitumour glutaminase-asparaginase from Pseudomonas 7A. J Biol Chem 251(17):5375-5380
62. Holcenberg JS, Ericsson L, Roberts J (1978) Amino acid sequence of the diazooxonorleucine binding site of Acinetobacter and Pseudomonas 7A glutaminase-asparaginase enzymes. Biochemistry 17(3):411-417
63. Holle LM (1997) Pegaspargase: an alternative? Ann Pharmacother 31(5):616-624
64. Howlader N, Noone AM, Krapcho M et al (eds) (2010) SEER cancer statistics review, 1975-2008. National Cancer Institute, Bethesda
65. Imada A, Igarasi S, Nakahama K et al (1973) Asparaginase and glutaminase activities of micro organisms. J Gen Microbiol 76(1):85-99
66. Inada Y, Furukawa M SH et al (1995) Biomedical and biotechnological applications of PEG and PM modified proteins. Trends Biotechnol 13(3):86-91
67. Jakubas BP, Kuli MK, Giebel S et al (2008) Use of L-asparaginase in acute lymphoblastic leukemia: recommendations of the Polish Adult Leukemia Group. Pol Arch Med Wewn 118(11):664-669
68. Jarrar M, Gaynon PS, Periclou AP et al (2006) Asparagine depletion after pegylated E. Coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: a children's oncology group study (CCG-1941). Pediatr Blood Cancer 47(2):141-146
69. Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58(2):71-96
70. Keating MJ, Holmes R, Lerner SH et al (1993) L-asparaginase and PEG asparaginase-past, present and future. Leuk Lymphoma 10:153-157
71. Keefer JF, Moraga DA, Schuster SM (1985) Amino acid content of L5178Y and L5178Y/L-ASE cells after L-asparaginase treatment. Biochem Med 34(2):135-142
72. Khushoo A, Pal Y, Mukherjee KJ (2005) Optimization of extracellular production of recombinant asparaginase in Escherichia coli in shake flask and bioreactor. Appl Microbiol Biotechnol 68(2):189-197
73. Kidd JG (1953) Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. I. Course of transplanted cancers of various kinds in mice and rats given guinea pig serum, horse serum, or rabbit serum. J Exp Med 98(6):565-582
74. Kidd JG, Sobin LH (1966) The incorporation of L-asparagine-14C by lymphoma 6C3HED cells: its inhibition by guinea pig serum. Cancer Res 26(2):208-211
75. Kotzia GA, Labrou NE (2007) L-asparaginase from Erwinia chrysanthemi 3937: cloning, expression and characterization. J Biotechnol 127(4):657-669
76. Lang S (1904) Uber desamidierung im Tierkorper. Beitr chem Physiol Pathol 5:321-345
77. Law AS, Wriston JC (1971) Purification and properties of Bacillus coagulans L-asparaginase. Arch Biochem Biophys 147(2):4744-4752
78. Lebedeva ZI, Kabanova EA, Berezov TT (1988) The nature of functional group of active centers of anti-tumour glutamine-(asparagine-) ase. Bull Exp Biol Med 105(4):426-429
79. Lee SM, Wroble MH, Ross JT (1989) L-asparaginase from Erwinia carotovora. An improved recovery and purification process using affinity chromatography. Appl Biochem Biotechnol 22(1):1-11
80. Mashburn LT, Wriston JC (1964) Tumor inhibitory effect of L-asparaginase from Escherichia coli. Arch Biochem Biophys 105:450-452
81. Miniero R, Pastore G, Saracco P et al (1986) Hemostatic changes in children with acute lymphoblastic leukemia treated according to two different L-asparaginase schedules. Am J Pediatr Hematol Oncol 8(2):116-120
82. Mitchell LG, Halton JM, Vegh PA et al (1994) Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia. Am J Pediatr Hematol Oncol 16(2):120-126
83. Moghrabi A, Levy DE, Asselin B et al (2007) Results of the Dana-Farber Cancer Institute ALL consortium protocol 95-01 for children with acute lymphoblastic leukemia. Blood 109(3):896-904
84. Mukharjee J, Majumdar S, Scheper T (2000) Studies on nutritional and oxygen requirements for production of L-asparaginase by Enterobacter aerogenes. Appl Microbiol Biotechnol 53(2):180-184
85. Müller HJ, Boos J (1998) Use of L-asparaginase in childhood ALL. Crit Rev Oncol Hematol 28(2):97-113
86. Nowak-Gottl U, Heinecke A, Von Kries R et al (2001) Thrombotic events revisited in children with acute lymphoblastic leukemia: impact of concomitant Escherichia coli asparaginase/prednisone administration. Thromb Res 103(3):165-172
87. Nowak-Göttl U, Ahlke E, Fleischhack G et al (2003) Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration. Blood 101(7):2529-2533
88. Oettgen HF, Old LJ, Boyse EA et al (1967) Inhibition of leukemias in man by L-asparaginase. Cancer Res 27(12):2619-2631
89. Panosyan EH, Grigoryan RS, Avramis IA et al (2004) Deamination of glutamine is a prerequisite for optimal asparagine deamination by asparaginases in vivo (CCG-1961). Anticancer Res 24(2C):1121-1125
90. Peterson RE, Ciegler A (1972) Factors influencing L-asparaginase production by Erwinia aroideae. Appl Microbiol 23(3):671-673
91. Pieters R, Hunger SP, Boos J et al (2011) L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase. Cancer 117(2):238-249
92. Prager Morton D, Baechtel Samuel F, Heifetza A (1982) In: Jeljaszewicz J, Pulverer G, Roszkowski W (eds) Bacteria and cancer. Academic, London
93. Pui CH (2010) Recent research advances in childhood acute lymphoblastic leukemia. J Formos Med Assoc 109(11):777-787
94. Raha SK, Roy SK, Dey S et al (1990) Purification and properties of an L-asparaginase from Cylindrocarpon obtusisporum MB-10. Biochem Int 21(6):987-1000
95. Revel-Vilk S (2006) Central venous line-related thrombosis in children. Acta Haematol 115(3-4):201-206
96. Ronghe M, Burke GA, Lowis SP et al (2001) Remission induction therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of vincristine, corticosteroids, L asparaginase and anthracyclines. Cancer Treat Rev 27(6):327-337
97. Sahoo S, Hart J (2003) Histopathological features of L-asparaginase-induced liver disease. Semin Liver Dis 23(3):295-299
98. Schwartz JH, Reeves J Y, Broome JD (1966) Two L-asparaginases from E. coli and their action against tumors. Proc Natl Acad Sci USA 56(5):1516-1519
99. Selvakumar N (1979) Studies on L-asparaginase (antileukaemic agent) from coastal area of Porto novo. PhD thesis, Annamalai University, Chidambaram, India
100. Sherr CJ (2004) Principles of tumor suppression. Cell 116(2):235-246
101. Shrivastava A, Khan AA, Jain SK et al (2010) Biotechnological advancement in isolation of antineoplastic compounds from natural origin: a novel source of L-asparaginase. Acta Biomed 81(2):104-108
102. Sieciechowicz KA, Ireland RJ (1989) Isolation and properties of an asparaginase from leaves of Pisum sativum. Phytochemistry 28(9):2275-2279
103. Sieciechowicz KA, Joy KW, Ireland RJ (1988a) Diurnal changes in asparaginase activity in pea leaves. I. The requirement for light for increased activity. J Exp Bot 39(6):695-706
104. Sieciechowicz KA, Ireland RJ, Joy KW (1988b) Diurnal changes in asparaginase activity in pea leaves. II. Regulation of activity. J Exp Bot 39:707-721
105. Sinha A, Manna S, Roy SK et al (1991) Induction of L-asparaginase synthesis in Vibrio proteus. Indian J Med Res 93:289-292
106. Sobin LH, Kidd JG (1965) A metabolic difference between two lines of lymphoma 6C3HED cells in relation to asparagine. Proc Soc Exp Biol Med 119:325-327
107. Sobin LH, Kidd JG (1966) Alterations in protein and nucleic acid metabolism of lymphoma 6C3HED-OG cells in mice given guinea pig serum. J Exp Med 123(1):55-74
108. Story MD, Voehring DW, Stephens LC et al (1993) L-asparaginase kills lymphoma cells by apoptosis. Cancer Chemother Pharmacol 32(2):129-133
109. Takase K, Takagi S, Okawa H et al (1985) Analysis of effect of L-asparaginase on the cell cycle of leukemic T cells by flow cytometry. Nippon Ketsueki Gakkai Zasshi 48(1):159-163
110. Thorburn AL (1983) Paul Ehrlich: pioneer of chemotherapy and cure by arsenic (1854-1915). Br J Vener Dis 59(6):404-405
111. Tosa T, Sano R, Yamamota K et al (1971) L-Asparaginase from Proteus vulgaris. Appl Microbiol 22(3):387-392
112. Trichopoulos D, Li FP, Hunter DJ (1996) What causes cancer? Sci Am 275(3):80
113. Villa P, Corada M, Bartošek I (1986) L-asparaginase effects on inhibition of protein synthesis and lowering of the glutamine content in cultured hepatocytes. Toxicol Lett 32(3):235-241
114. Vogelstein B, Kinzler KW (2002) The genetic basis of human cancer, 2nd edn. McGraw Hill, Toronto
115. Wang B, Relling MV, Storm MC et al (2003) Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients. Leukemia 17(8):1583-1588
116. Waye MM, Stanners CP (1981) Role of asparagine synthetase and asparagyl-transfer RNA synthetase in the cell-killing activity of asparaginase in Chinese hamster ovary cell mutants. Cancer Res 41(8):3104-3106
117. Whelan HA, Wriston JC (1969) Purification and properties of asparaginase from Escherichia coli B. Biochemistry 8(6):2386-2393
118. Woo MH, Hak LJ, Storm MC et al (2000) Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol 18(7):1525-1532
119. Worton KS, Kerbel RS, Andrulis IL (1991) Hypomethylation and reactivation of the asparagine synthetase gene induced by L asparaginase and ethyl methanesulfonate. Cancer Res 51(3):985-989
120. Wriston JC, Yellin TO (1973) L-asparaginase: a review. Adv Enzymol Relat Areas Mol Biol 39:185-248
121. Yellin TO, Wriston JC (1966) Antagonism of purified asparaginase from guinea pig serum towards lymphoma. Science 151(713):998-999